<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-11-01" modified="2020-10-07" version="226">
<accession>P05783</accession>
<accession>Q53G38</accession>
<accession>Q5U0N8</accession>
<accession>Q9BW26</accession>
<name>K1C18_HUMAN</name>
<protein>
<recommendedName>
<fullName>Keratin, type I cytoskeletal 18</fullName>
</recommendedName>
<alternativeName>
<fullName>Cell proliferation-inducing gene 46 protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Cytokeratin-18</fullName>
<shortName>CK-18</shortName>
</alternativeName>
<alternativeName>
<fullName>Keratin-18</fullName>
<shortName>K18</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">KRT18</name>
<name type="synonym">CYK18</name>
<name type="ORF">PIG46</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="Differentiation" volume="33" first="61" last="68">
<title>Comparison of mouse and human keratin 18: a component of intermediate filaments expressed prior to implantation.</title>
<authorList>
<person name="Oshima R.G."/>
<person name="Millan J.L."/>
<person name="Cecena G."/>
</authorList>
<dbReference type="PubMed" id="2434380"/>
<dbReference type="DOI" id="10.1111/j.1432-0436.1986.tb00411.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2004-09" db="EMBL/GenBank/DDBJ databases">
<title>Identification of a cell proliferation-inducing gene.</title>
<authorList>
<person name="Kim J.W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Cervix</tissue>
<tissue>Colon</tissue>
<tissue>Pancreas</tissue>
<tissue>Placenta</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1988" name="Mol. Cell. Biol." volume="8" first="1540" last="1550">
<title>Cloning of the human keratin 18 gene and its expression in nonepithelial mouse cells.</title>
<authorList>
<person name="Kulesh D.A."/>
<person name="Oshima R.G."/>
</authorList>
<dbReference type="PubMed" id="2454392"/>
<dbReference type="DOI" id="10.1128/mcb.8.4.1540"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-167</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1986" name="Differentiation" volume="33" first="69" last="85">
<title>Cytokeratin expression in simple epithelia. III. Detection of mRNAs encoding human cytokeratins nos. 8 and 18 in normal and tumor cells by hybridization with cDNA sequences in vitro and in situ.</title>
<authorList>
<person name="Leube R.E."/>
<person name="Bosch F.X."/>
<person name="Romano V."/>
<person name="Zimbelmann R."/>
<person name="Hofler H."/>
<person name="Franke W.W."/>
</authorList>
<dbReference type="PubMed" id="2434381"/>
<dbReference type="DOI" id="10.1111/j.1432-0436.1986.tb00412.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 7-430</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Vulva</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1986" name="Differentiation" volume="30" first="244" last="253">
<title>Cytokeratin expression in simple epithelia. I. Identification of mRNA coding for human cytokeratin no. 18 by a cDNA clone.</title>
<authorList>
<person name="Romano V."/>
<person name="Hatzfeld M."/>
<person name="Magin T.M."/>
<person name="Zimbelmann R."/>
<person name="Franke W.W."/>
<person name="Maier G."/>
<person name="Ponstingl H."/>
</authorList>
<dbReference type="PubMed" id="2422083"/>
<dbReference type="DOI" id="10.1111/j.1432-0436.1986.tb00787.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 199-430</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1997" name="Electrophoresis" volume="18" first="605" last="613">
<title>A two-dimensional gel database of human colon carcinoma proteins.</title>
<authorList>
<person name="Ji H."/>
<person name="Reid G.E."/>
<person name="Moritz R.L."/>
<person name="Eddes J.S."/>
<person name="Burgess A.W."/>
<person name="Simpson R.J."/>
</authorList>
<dbReference type="PubMed" id="9150948"/>
<dbReference type="DOI" id="10.1002/elps.1150180344"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="3901" last="3906">
<title>Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18.</title>
<authorList>
<person name="Chou C.F."/>
<person name="Smith A.J."/>
<person name="Omary M.B."/>
</authorList>
<dbReference type="PubMed" id="1371281"/>
</citation>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1994" name="J. Cell Biol." volume="127" first="161" last="171">
<title>Identification of the major physiologic phosphorylation site of human keratin 18: potential kinases and a role in filament reorganization.</title>
<authorList>
<person name="Ku N.O."/>
<person name="Omary M.B."/>
</authorList>
<dbReference type="PubMed" id="7523419"/>
<dbReference type="DOI" id="10.1083/jcb.127.1.161"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-53</scope>
<scope>MUTAGENESIS OF SER-2; SER-7; SER-10; SER-15; SER-18; SER-23; SER-30; SER-31; SER-34; SER-42; SER-44; SER-47; SER-49; SER-51 AND SER-53</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="11820" last="11827">
<title>Identification and mutational analysis of the glycosylation sites of human keratin 18.</title>
<authorList>
<person name="Ku N.-O."/>
<person name="Omary M.B."/>
</authorList>
<dbReference type="PubMed" id="7538124"/>
<dbReference type="DOI" id="10.1074/jbc.270.20.11820"/>
</citation>
<scope>GLYCOSYLATION AT SER-30; SER-31 AND SER-49</scope>
<scope>MUTAGENESIS OF SER-30; SER-31 AND SER-49</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT SER-2</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1995" name="J. Cell Biol." volume="131" first="1303" last="1314">
<title>Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant.</title>
<authorList>
<person name="Ku N.O."/>
<person name="Michie S."/>
<person name="Oshima R.G."/>
<person name="Omary M.B."/>
</authorList>
<dbReference type="PubMed" id="8522591"/>
<dbReference type="DOI" id="10.1083/jcb.131.5.1303"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ARG-90</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1996" name="J. Cell Biol." volume="133" first="345" last="357">
<title>14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor.</title>
<authorList>
<person name="Liao J."/>
<person name="Omary M.B."/>
</authorList>
<dbReference type="PubMed" id="8609167"/>
<dbReference type="DOI" id="10.1083/jcb.133.2.345"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH YWHAE; YWHAH AND YWHAZ</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1997" name="J. Cell Biol." volume="138" first="1379" last="1394">
<title>Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis.</title>
<authorList>
<person name="Caulin C."/>
<person name="Salvesen G.S."/>
<person name="Oshima R.G."/>
</authorList>
<dbReference type="PubMed" id="9298992"/>
<dbReference type="DOI" id="10.1083/jcb.138.6.1379"/>
</citation>
<scope>FUNCTION</scope>
<scope>CLEAVAGE BY CASPASES</scope>
<scope>MUTAGENESIS OF SER-53 AND ASP-238</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1998" name="EMBO J." volume="17" first="1892" last="1906">
<title>Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins.</title>
<authorList>
<person name="Ku N.O."/>
<person name="Liao J."/>
<person name="Omary M.B."/>
</authorList>
<dbReference type="PubMed" id="9524113"/>
<dbReference type="DOI" id="10.1093/emboj/17.7.1892"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH YWHAE AND YWHAZ</scope>
<scope>PHOSPHORYLATION AT SER-34</scope>
<scope>MUTAGENESIS OF SER-34 AND SER-53</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="14910" last="14915">
<title>Dissection of protein linkage between keratins and pinin, a protein with dual location at desmosome-intermediate filament complex and in the nucleus.</title>
<authorList>
<person name="Shi J."/>
<person name="Sugrue S.P."/>
</authorList>
<dbReference type="PubMed" id="10809736"/>
<dbReference type="DOI" id="10.1074/jbc.275.20.14910"/>
</citation>
<scope>INTERACTION WITH PNN</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="34521" last="34527">
<title>Identification of Mrj, a DnaJ/Hsp40 family protein, as a keratin 8/18 filament regulatory protein.</title>
<authorList>
<person name="Izawa I."/>
<person name="Nishizawa M."/>
<person name="Ohtakara K."/>
<person name="Ohtsuka K."/>
<person name="Inada H."/>
<person name="Inagaki M."/>
</authorList>
<dbReference type="PubMed" id="10954706"/>
<dbReference type="DOI" id="10.1074/jbc.m003492200"/>
</citation>
<scope>INTERACTION WITH DNAJB6</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="J. Cell Biol." volume="155" first="415" last="426">
<title>Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD.</title>
<authorList>
<person name="Inada H."/>
<person name="Izawa I."/>
<person name="Nishizawa M."/>
<person name="Fujita E."/>
<person name="Kiyono T."/>
<person name="Takahashi T."/>
<person name="Momoi T."/>
<person name="Inagaki M."/>
</authorList>
<dbReference type="PubMed" id="11684708"/>
<dbReference type="DOI" id="10.1083/jcb.200103078"/>
</citation>
<scope>INTERACTION WITH TRADD</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="Biochemistry" volume="43" first="1283" last="1295">
<title>Conformational changes in the rod domain of human keratin 8 following heterotypic association with keratin 18 and its implication for filament stability.</title>
<authorList>
<person name="Waseem A."/>
<person name="Karsten U."/>
<person name="Leigh I.M."/>
<person name="Purkis P."/>
<person name="Waseem N.H."/>
<person name="Lane E.B."/>
</authorList>
<dbReference type="PubMed" id="14756564"/>
<dbReference type="DOI" id="10.1021/bi035072s"/>
</citation>
<scope>ASSOCIATION WITH KRT8</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="Hepatology" volume="40" first="459" last="466">
<title>Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease.</title>
<authorList>
<person name="Toivola D.M."/>
<person name="Ku N.O."/>
<person name="Resurreccion E.Z."/>
<person name="Nelson D.R."/>
<person name="Wright T.L."/>
<person name="Omary M.B."/>
</authorList>
<dbReference type="PubMed" id="15368451"/>
<dbReference type="DOI" id="10.1002/hep.20277"/>
</citation>
<scope>PHOSPHORYLATION AT SER-34 AND SER-53</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2004" name="Proteomics" volume="4" first="3833" last="3844">
<title>Global proteomic approach unmasks involvement of keratins 8 and 18 in the delivery of cystic fibrosis transmembrane conductance regulator (CFTR)/deltaF508-CFTR to the plasma membrane.</title>
<authorList>
<person name="Davezac N."/>
<person name="Tondelier D."/>
<person name="Lipecka J."/>
<person name="Fanen P."/>
<person name="Demaugre F."/>
<person name="Debski J."/>
<person name="Dadlez M."/>
<person name="Schrattenholz A."/>
<person name="Cahill M.A."/>
<person name="Edelman A."/>
</authorList>
<dbReference type="PubMed" id="15529338"/>
<dbReference type="DOI" id="10.1002/pmic.200400850"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MUTATED CFTR</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="J. Cell Sci." volume="118" first="1081" last="1090">
<title>Identification of trichoplein, a novel keratin filament-binding protein.</title>
<authorList>
<person name="Nishizawa M."/>
<person name="Izawa I."/>
<person name="Inoko A."/>
<person name="Hayashi Y."/>
<person name="Nagata K."/>
<person name="Yokoyama T."/>
<person name="Usukura J."/>
<person name="Inagaki M."/>
</authorList>
<dbReference type="PubMed" id="15731013"/>
<dbReference type="DOI" id="10.1242/jcs.01667"/>
</citation>
<scope>INTERACTION WITH TCHP</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2005" name="Proteomics" volume="5" first="2227" last="2237">
<title>Proteomic profiling of cellular proteins interacting with the hepatitis C virus core protein.</title>
<authorList>
<person name="Kang S.-M."/>
<person name="Shin M.-J."/>
<person name="Kim J.-H."/>
<person name="Oh J.-W."/>
</authorList>
<dbReference type="PubMed" id="15846844"/>
<dbReference type="DOI" id="10.1002/pmic.200401093"/>
</citation>
<scope>INTERACTION WITH HEPATITIS C VIRUS CORE PROTEIN (MICROBIAL INFECTION)</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2006" name="J. Pharmacol. Exp. Ther." volume="317" first="500" last="505">
<title>Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network.</title>
<authorList>
<person name="Lipecka J."/>
<person name="Norez C."/>
<person name="Bensalem N."/>
<person name="Baudouin-Legros M."/>
<person name="Planelles G."/>
<person name="Becq F."/>
<person name="Edelman A."/>
<person name="Davezac N."/>
</authorList>
<dbReference type="PubMed" id="16424149"/>
<dbReference type="DOI" id="10.1124/jpet.105.097667"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-53</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="8219" last="8227">
<title>Interleukin-6 induces keratin expression in intestinal epithelial cells: potential role of keratin-8 in interleukin-6-induced barrier function alterations.</title>
<authorList>
<person name="Wang L."/>
<person name="Srinivasan S."/>
<person name="Theiss A.L."/>
<person name="Merlin D."/>
<person name="Sitaraman S.V."/>
</authorList>
<dbReference type="PubMed" id="17213200"/>
<dbReference type="DOI" id="10.1074/jbc.m604068200"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-34; SER-42; SER-60; THR-302 AND SER-399</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-131 AND LYS-426</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="34062" last="34071">
<title>O-GlcNAcylation determines the solubility, filament organization, and stability of keratins 8 and 18.</title>
<authorList>
<person name="Srikanth B."/>
<person name="Vaidya M.M."/>
<person name="Kalraiya R.D."/>
</authorList>
<dbReference type="PubMed" id="20729549"/>
<dbReference type="DOI" id="10.1074/jbc.m109.098996"/>
</citation>
<scope>GLYCOSYLATION AT SER-30; SER-31 AND SER-49</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; SER-15; SER-34; SER-42; SER-60; THR-65; SER-100; SER-319; SER-399 AND THR-404</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.013680.01" last="M111.013680.15">
<title>Systematic analysis of protein pools, isoforms, and modifications affecting turnover and subcellular localization.</title>
<authorList>
<person name="Ahmad Y."/>
<person name="Boisvert F.M."/>
<person name="Lundberg E."/>
<person name="Uhlen M."/>
<person name="Lamond A.I."/>
</authorList>
<dbReference type="PubMed" id="22002106"/>
<dbReference type="DOI" id="10.1074/mcp.m111.013680"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2013" name="J. Cell Sci." volume="126" first="4721" last="4731">
<title>A novel mechanism of keratin cytoskeleton organization through casein kinase Ialpha and FAM83H in colorectal cancer.</title>
<authorList>
<person name="Kuga T."/>
<person name="Kume H."/>
<person name="Kawasaki N."/>
<person name="Sato M."/>
<person name="Adachi J."/>
<person name="Shiromizu T."/>
<person name="Hoshino I."/>
<person name="Nishimori T."/>
<person name="Matsubara H."/>
<person name="Tomonaga T."/>
</authorList>
<dbReference type="PubMed" id="23902688"/>
<dbReference type="DOI" id="10.1242/jcs.129684"/>
</citation>
<scope>INTERACTION WITH FAM83H</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-18; SER-34; SER-49; THR-52; SER-60; SER-93; SER-305; SER-319; SER-323 AND SER-399</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-65; SER-177; SER-305; SER-398; SER-399; SER-401 AND THR-404</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-45 AND ARG-55</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-426</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-81; LYS-247; LYS-370; LYS-372; LYS-417 AND LYS-426</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1997" name="J. Clin. Invest." volume="99" first="19" last="23">
<title>Mutation of human keratin 18 in association with cryptogenic cirrhosis.</title>
<authorList>
<person name="Ku N.-O."/>
<person name="Wright T.L."/>
<person name="Terrault N.A."/>
<person name="Gish R."/>
<person name="Omary M.B."/>
</authorList>
<dbReference type="PubMed" id="9011570"/>
<dbReference type="DOI" id="10.1172/jci119127"/>
</citation>
<scope>VARIANT CIRRH LEU-128</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="6063" last="6068">
<title>Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies.</title>
<authorList>
<person name="Ku N.-O."/>
<person name="Darling J.M."/>
<person name="Krams S.M."/>
<person name="Esquivel C.O."/>
<person name="Keeffe E.B."/>
<person name="Sibley R.K."/>
<person name="Lee Y.M."/>
<person name="Wright T.L."/>
<person name="Omary M.B."/>
</authorList>
<dbReference type="PubMed" id="12724528"/>
<dbReference type="DOI" id="10.1073/pnas.0936165100"/>
</citation>
<scope>VARIANTS CIRRH ALA-103; LEU-128; GLN-261 AND ARG-340</scope>
<scope>VARIANT THR-230</scope>
</reference>
<comment type="function">
<text evidence="11 19 22 23 29 31 34 35">Involved in the uptake of thrombin-antithrombin complexes by hepatic cells (By similarity). When phosphorylated, plays a role in filament reorganization. Involved in the delivery of mutated CFTR to the plasma membrane. Together with KRT8, is involved in interleukin-6 (IL-6)-mediated barrier protection.</text>
</comment>
<comment type="subunit">
<text evidence="11 12 14 15 16 19 20 25 32 35">Heterotetramer of two type I and two type II keratins. KRT18 associates with KRT8. Interacts with the thrombin-antithrombin complex (By similarity). Interacts with PNN and mutated CFTR. Interacts with YWHAE, YWHAH and YWHAZ only when phosphorylated. Interacts with DNAJB6, TCHP and TRADD. Interacts with FAM83H (PubMed:23902688). Interacts with EPPK1 (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="21">(Microbial infection) Interacts with hepatitis C virus/HCV core protein.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-949378">
<id>Q14457</id>
<label>BECN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-8643161">
<id>Q9NX04</id>
<label>C1orf109</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-10247802">
<id>Q8IYE0-2</id>
<label>CCDC146</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-10175300">
<id>Q8TD31-3</id>
<label>CCHCR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-1053164">
<id>O75190</id>
<label>DNAJB6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-743105">
<id>Q5JVL4</id>
<label>EFHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-618309">
<id>Q08379</id>
<label>GOLGA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-2514791">
<id>Q96CS2</id>
<label>HAUS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-16429135">
<id>A0A0S2Z4Q4</id>
<label>HGS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-740220">
<id>O14964</id>
<label>HGS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
<label>IKBKG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-14069005">
<id>Q9BVG8-5</id>
<label>KIFC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-702198">
<id>P02538</id>
<label>KRT6A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-2564105">
<id>P48668</id>
<label>KRT6C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-2952676">
<id>Q3SY84</id>
<label>KRT71</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-2514135">
<id>Q5XKE5</id>
<label>KRT79</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-297852">
<id>P05787</id>
<label>KRT8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-739648">
<id>Q14533</id>
<label>KRT81</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-2830524">
<id>O75022</id>
<label>LILRB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-5324932">
<id>Q9BQ69</id>
<label>MACROD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-475646">
<id>P07196</id>
<label>NEFL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-744782">
<id>Q9Y5B8</id>
<label>NME7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-9087684">
<id>Q13835-2</id>
<label>PKP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-16437709">
<id>A0A0S2Z505</id>
<label>PSTPIP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-1504830">
<id>Q9P2K3-2</id>
<label>RCOR3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-6872807">
<id>Q8N0S2</id>
<label>SYCE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-750487">
<id>Q8WW24</id>
<label>TEKT4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-359215">
<id>Q15628</id>
<label>TRADD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-346882">
<id>Q99816</id>
<label>TSG101</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297888">
<id>P05783</id>
</interactant>
<interactant intactId="EBI-2504426">
<id>B7UM99</id>
<label>tir</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
<location>Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>Nucleolus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="23 26 27 28">Expressed in colon, placenta, liver and very weakly in exocervix. Increased expression observed in lymph nodes of breast carcinoma.</text>
</comment>
<comment type="induction">
<text evidence="23">By IL6/interleukin-6.</text>
</comment>
<comment type="PTM">
<text evidence="18 22 23 29 32 35">Phosphorylation at Ser-34 increases during mitosis. Hyperphosphorylated at Ser-53 in diseased cirrhosis liver. Phosphorylation increases by IL-6.</text>
</comment>
<comment type="PTM">
<text evidence="34">Proteolytically cleaved by caspases during epithelial cell apoptosis. Cleavage occurs at Asp-238 by either caspase-3, caspase-6 or caspase-7.</text>
</comment>
<comment type="PTM">
<text>O-GlcNAcylation increases solubility, and decreases stability by inducing proteasomal degradation.</text>
</comment>
<comment type="disease" evidence="17 33">
<disease id="DI-01454">
<name>Cirrhosis</name>
<acronym>CIRRH</acronym>
<description>A liver disease characterized by severe panlobular liver-cell swelling with Mallory body formation, prominent pericellular fibrosis, and marked deposits of copper. Clinical features include abdomen swelling, jaundice and pulmonary hypertension.</description>
<dbReference type="MIM" id="215600"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>There are two types of cytoskeletal and microfibrillar keratin: I (acidic; 40-55 kDa) and II (neutral to basic; 56-70 kDa).</text>
</comment>
<comment type="similarity">
<text evidence="13">Belongs to the intermediate filament family.</text>
</comment>
<comment type="online information" name="Human Intermediate Filament Mutation Database">
<link uri="http://www.interfil.org"/>
</comment>
<dbReference type="EMBL" id="X12881">
<property type="protein sequence ID" value="CAA31375.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY762101">
<property type="protein sequence ID" value="AAX07828.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT019412">
<property type="protein sequence ID" value="AAV38219.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223093">
<property type="protein sequence ID" value="BAD96813.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000180">
<property type="protein sequence ID" value="AAH00180.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000698">
<property type="protein sequence ID" value="AAH00698.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC004253">
<property type="protein sequence ID" value="AAH04253.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC008636">
<property type="protein sequence ID" value="AAH08636.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC020982">
<property type="protein sequence ID" value="AAH20982.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC072017">
<property type="protein sequence ID" value="AAH72017.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF179904">
<property type="protein sequence ID" value="AAA59461.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X12883">
<property type="protein sequence ID" value="CAA31377.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X12876">
<property type="protein sequence ID" value="CAA31369.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31809.1"/>
<dbReference type="PIR" id="S05481">
<property type="entry name" value="S05481"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000215.1">
<property type="nucleotide sequence ID" value="NM_000224.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_954657.1">
<property type="nucleotide sequence ID" value="NM_199187.1"/>
</dbReference>
<dbReference type="SMR" id="P05783"/>
<dbReference type="BioGRID" id="110073">
<property type="interactions" value="149"/>
</dbReference>
<dbReference type="DIP" id="DIP-633N"/>
<dbReference type="IntAct" id="P05783">
<property type="interactions" value="105"/>
</dbReference>
<dbReference type="MINT" id="P05783"/>
<dbReference type="STRING" id="9606.ENSP00000373487"/>
<dbReference type="GlyConnect" id="312">
<property type="glycosylation" value="3 N-Linked glycans (1 site), 1 O-Linked glycan (3 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="P05783">
<property type="glycosylation" value="4 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P05783"/>
<dbReference type="MetOSite" id="P05783"/>
<dbReference type="PhosphoSitePlus" id="P05783"/>
<dbReference type="SwissPalm" id="P05783"/>
<dbReference type="UniCarbKB" id="P05783"/>
<dbReference type="BioMuta" id="KRT18"/>
<dbReference type="DMDM" id="125083"/>
<dbReference type="SWISS-2DPAGE" id="P05783"/>
<dbReference type="CPTAC" id="CPTAC-1518"/>
<dbReference type="CPTAC" id="CPTAC-1519"/>
<dbReference type="EPD" id="P05783"/>
<dbReference type="jPOST" id="P05783"/>
<dbReference type="MassIVE" id="P05783"/>
<dbReference type="MaxQB" id="P05783"/>
<dbReference type="PaxDb" id="P05783"/>
<dbReference type="PeptideAtlas" id="P05783"/>
<dbReference type="PRIDE" id="P05783"/>
<dbReference type="ProteomicsDB" id="51857"/>
<dbReference type="TopDownProteomics" id="P05783"/>
<dbReference type="ABCD" id="P05783">
<property type="antibodies" value="2 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="271">
<property type="antibodies" value="3443 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3875"/>
<dbReference type="Ensembl" id="ENST00000388835">
<property type="protein sequence ID" value="ENSP00000373487"/>
<property type="gene ID" value="ENSG00000111057"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000388837">
<property type="protein sequence ID" value="ENSP00000373489"/>
<property type="gene ID" value="ENSG00000111057"/>
</dbReference>
<dbReference type="GeneID" id="3875"/>
<dbReference type="KEGG" id="hsa:3875"/>
<dbReference type="UCSC" id="uc001sbe.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3875"/>
<dbReference type="DisGeNET" id="3875"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000111057.10"/>
<dbReference type="GeneCards" id="KRT18"/>
<dbReference type="HGNC" id="HGNC:6430">
<property type="gene designation" value="KRT18"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000111057">
<property type="expression patterns" value="Tissue enhanced (placenta)"/>
</dbReference>
<dbReference type="MIM" id="148070">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="215600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P05783"/>
<dbReference type="OpenTargets" id="ENSG00000111057"/>
<dbReference type="PharmGKB" id="PA30217"/>
<dbReference type="eggNOG" id="ENOG502QUS8">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000153309"/>
<dbReference type="InParanoid" id="P05783"/>
<dbReference type="KO" id="K07604"/>
<dbReference type="OMA" id="YNMEMES"/>
<dbReference type="OrthoDB" id="711591at2759"/>
<dbReference type="PhylomeDB" id="P05783"/>
<dbReference type="TreeFam" id="TF332742"/>
<dbReference type="PathwayCommons" id="P05783"/>
<dbReference type="Reactome" id="R-HSA-6805567">
<property type="pathway name" value="Keratinization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6809371">
<property type="pathway name" value="Formation of the cornified envelope"/>
</dbReference>
<dbReference type="SignaLink" id="P05783"/>
<dbReference type="SIGNOR" id="P05783"/>
<dbReference type="BioGRID-ORCS" id="3875">
<property type="hits" value="76 hits in 877 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="KRT18">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Keratin_18"/>
<dbReference type="GenomeRNAi" id="3875"/>
<dbReference type="Pharos" id="P05783">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P05783"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="P05783">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000111057">
<property type="expression patterns" value="Expressed in adenohypophysis and 114 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P05783">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P05783">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005912">
<property type="term" value="C:adherens junction"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071944">
<property type="term" value="C:cell periphery"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034451">
<property type="term" value="C:centriolar satellite"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005882">
<property type="term" value="C:intermediate filament"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045095">
<property type="term" value="C:keratin filament"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005815">
<property type="term" value="C:microtubule organizing center"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0098641">
<property type="term" value="F:cadherin binding involved in cell-cell adhesion"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097110">
<property type="term" value="F:scaffold protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005198">
<property type="term" value="F:structural molecule activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0009653">
<property type="term" value="P:anatomical structure morphogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070268">
<property type="term" value="P:cornification"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0097191">
<property type="term" value="P:extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043000">
<property type="term" value="P:Golgi to plasma membrane CFTR protein transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097284">
<property type="term" value="P:hepatocyte apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045104">
<property type="term" value="P:intermediate filament cytoskeleton organization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031424">
<property type="term" value="P:keratinization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033209">
<property type="term" value="P:tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.5.1160">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR018039">
<property type="entry name" value="IF_conserved"/>
</dbReference>
<dbReference type="InterPro" id="IPR039008">
<property type="entry name" value="IF_rod_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR042180">
<property type="entry name" value="IF_rod_dom_coil1B"/>
</dbReference>
<dbReference type="InterPro" id="IPR027695">
<property type="entry name" value="Keratin-18"/>
</dbReference>
<dbReference type="InterPro" id="IPR002957">
<property type="entry name" value="Keratin_I"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23239">
<property type="entry name" value="PTHR23239"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23239:SF349">
<property type="entry name" value="PTHR23239:SF349"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00038">
<property type="entry name" value="Filament"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01248">
<property type="entry name" value="TYPE1KERATIN"/>
</dbReference>
<dbReference type="SMART" id="SM01391">
<property type="entry name" value="Filament"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00226">
<property type="entry name" value="IF_ROD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51842">
<property type="entry name" value="IF_ROD_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0403">Intermediate filament</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0416">Keratin</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="30">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Keratin, type I cytoskeletal 18" id="PRO_0000063666">
<location>
<begin position="2"/>
<end position="430"/>
</location>
</feature>
<feature type="domain" description="IF rod" evidence="13">
<location>
<begin position="80"/>
<end position="391"/>
</location>
</feature>
<feature type="region of interest" description="Head">
<location>
<begin position="2"/>
<end position="79"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for interaction with PNN" evidence="14">
<location>
<begin position="70"/>
<end position="373"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TRADD" evidence="16">
<location>
<begin position="77"/>
<end position="128"/>
</location>
</feature>
<feature type="region of interest" description="Coil 1A">
<location>
<begin position="80"/>
<end position="115"/>
</location>
</feature>
<feature type="region of interest" description="Linker 1">
<location>
<begin position="116"/>
<end position="132"/>
</location>
</feature>
<feature type="region of interest" description="Coil 1B">
<location>
<begin position="133"/>
<end position="224"/>
</location>
</feature>
<feature type="region of interest" description="Linker 12">
<location>
<begin position="225"/>
<end position="248"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNAJB6" evidence="15">
<location>
<begin position="243"/>
<end position="391"/>
</location>
</feature>
<feature type="region of interest" description="Coil 2">
<location>
<begin position="249"/>
<end position="387"/>
</location>
</feature>
<feature type="region of interest" description="Tail">
<location>
<begin position="388"/>
<end position="430"/>
</location>
</feature>
<feature type="site" description="Cleavage; by caspase-3, caspase-6 or caspase-7">
<location>
<begin position="238"/>
<end position="239"/>
</location>
</feature>
<feature type="site" description="Stutter">
<location>
<position position="271"/>
</location>
</feature>
<feature type="site" description="Stutter">
<location>
<position position="331"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="30">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="7"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 6">
<location>
<position position="10"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 5">
<location>
<position position="15"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="18"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; alternate" evidence="12">
<location>
<position position="30"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; alternate" evidence="12">
<location>
<position position="31"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1" evidence="2 5 6 18 35">
<location>
<position position="34"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="12">
<location>
<position position="36"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5">
<location>
<position position="42"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="7">
<location>
<position position="45"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; alternate" evidence="6">
<location>
<position position="49"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPKAPK2 and MAPKAPK3" evidence="12 36">
<location>
<position position="51"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="52"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CAMK, PKC/PRKCE and AURKA" evidence="18 22 29">
<location>
<position position="53"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="7">
<location>
<position position="55"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 5 6">
<location>
<position position="60"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 8">
<location>
<position position="65"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="93"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="100"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="131"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="177"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2">
<location>
<position position="302"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8">
<location>
<position position="305"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6">
<location>
<position position="319"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="323"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="398"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5 6 8">
<location>
<position position="399"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="401"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 8">
<location>
<position position="404"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="4">
<location>
<position position="426"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) serine; alternate" id="CAR_000175" evidence="24 30">
<location>
<position position="30"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) serine; alternate" id="CAR_000193" evidence="24 30">
<location>
<position position="31"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) serine; alternate" id="CAR_000194" evidence="24 30">
<location>
<position position="49"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="10">
<location>
<position position="81"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="10">
<location>
<position position="247"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="10">
<location>
<position position="370"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="10">
<location>
<position position="372"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="10">
<location>
<position position="417"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="9">
<location>
<position position="426"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="10">
<location>
<position position="426"/>
</location>
</feature>
<feature type="sequence variant" description="In CIRRH; dbSNP:rs61136606." id="VAR_023054" evidence="17">
<original>T</original>
<variation>A</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="sequence variant" description="In CIRRH; interfers with the ability to form normal filaments; dbSNP:rs57758506." id="VAR_003852" evidence="17 33">
<original>H</original>
<variation>L</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs58472472." id="VAR_023055" evidence="17">
<original>S</original>
<variation>T</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In CIRRH; dbSNP:rs57354642." id="VAR_023056" evidence="17">
<original>R</original>
<variation>Q</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In CIRRH; dbSNP:rs57370769." id="VAR_023057" evidence="17">
<original>G</original>
<variation>R</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-7 and A-10." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-2 and A-10." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-2 and A-7." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-18 and A-23. Abolishes phosphorylation; when associated with A-18; A-34; A-47; A-49; A-51 and A-53." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-15 and A-23. Abolishes phosphorylation; when associated with A-15; A-34; A-47; A-49; A-51 and A-53." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-15 and A-18." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-31 and A-34, or with A-31; A-44 and A-51. Abolishes glycosylation but does not affect binding to YWHAE and YWHAZ; when associated with A-31 and A-49." evidence="29 30">
<original>S</original>
<variation>A</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-30 and A-34, or with A-30; A-44 and A-51. Abolishes glycosylation but does not affect binding to YWHAE and YWHAZ; when associated with A-30 and A-49." evidence="29 30">
<original>S</original>
<variation>A</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-30 and A-31. Abolishes phosphorylation; when associated with A-15; A-18; A-47; A-49; A-51 and A-53. Abolishes binding to YWHAE and YWHAZ; and when associated with A-53." evidence="29 35">
<original>S</original>
<variation>A</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to YWHAE and YWHAZ." evidence="29 35">
<original>S</original>
<variation>D</variation>
<variation>E</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-44." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-42, or with A-30; A-31 and A-51." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-49. Abolishes phosphorylation; when associated with A-49; A-51 and A-53, or with A-15; A-18; A-34; A-49; A-51 and A-53." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-47. Abolishes phosphorylation; when associated with A-47; A-51 and A-53, or with A-15; A-18; A-34; A-47; A-51 and A-53. Abolishes glycosylation but does not affect binding to YWHAE and YWHAZ; when associated with A-30 and A-31." evidence="29 30">
<original>S</original>
<variation>A</variation>
<location>
<position position="49"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation; when associated with A-30; A-31 and A-47. Abolishes phosphorylation; when associated with A-47; A-49 and A-53, or with A-15; A-18; A-34; A-47; A-49 and A-53." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="51"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation; when associated with A-47; A-49 and A-51, or with A-15; A-18; A-34; A-47; A-49 and A-51. Abolishes binding to YWHAE and YWHAZ; when associated with A-34. No effect on caspase cleavage during apoptosis." evidence="29 34 35">
<original>S</original>
<variation>A</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="mutagenesis site" description="In transgenic mice, induces marked disruption of liver and pancreas keratin filament network. Increases phosphorylation and glycosylation." evidence="31">
<original>R</original>
<variation>C</variation>
<variation>H</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents cleavage by caspase-6 during apoptosis. Induces aggregates of keratin filaments in an altered organization." evidence="34">
<original>D</original>
<variation>E</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAH00698." ref="5" evidence="36">
<original>Y</original>
<variation>H</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; CAA31369." ref="8" evidence="36">
<original>E</original>
<variation>Q</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAD96813." ref="3" evidence="36">
<original>E</original>
<variation>G</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; CAA31369." ref="8" evidence="36">
<original>A</original>
<variation>S</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; CAA31369." ref="8" evidence="36">
<original>D</original>
<variation>R</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; CAA31369." ref="8" evidence="36">
<original>S</original>
<variation>R</variation>
<location>
<position position="312"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17924679"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250"/>
<evidence key="12" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P05784"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01188"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10809736"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10954706"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11684708"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12724528"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15368451"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15529338"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15731013"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15846844"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16424149"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17213200"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20729549"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23902688"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2422083"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2434380"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2434381"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7523419"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7538124"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8522591"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8609167"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9011570"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9298992"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9524113"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000305"/>
<sequence length="430" mass="48058" checksum="1E5604C6BCC7A17A" modified="2007-01-23" version="2">MSFTTRSTFSTNYRSLGSVQAPSYGARPVSSAASVYAGAGGSGSRISVSRSTSFRGGMGSGGLATGIAGGLAGMGGIQNEKETMQSLNDRLASYLDRVRSLETENRRLESKIREHLEKKGPQVRDWSHYFKIIEDLRAQIFANTVDNARIVLQIDNARLAADDFRVKYETELAMRQSVENDIHGLRKVIDDTNITRLQLETEIEALKEELLFMKKNHEEEVKGLQAQIASSGLTVEVDAPKSQDLAKIMADIRAQYDELARKNREELDKYWSQQIEESTTVVTTQSAEVGAAETTLTELRRTVQSLEIDLDSMRNLKASLENSLREVEARYALQMEQLNGILLHLESELAQTRAEGQRQAQEYEALLNIKVKLEAEIATYRRLLEDGEDFNLGDALDSSNSMQTIQKTTTRRIVDGKVVSETNDTKVLRH</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

